A year after receiving FDA clearance for their smartphone-connected glucometer, Israel-based DarioHealth is in good shape, reporting record revenues, an increasing user base and big plans to expand with payers, new markets and partnerships to monetize big data.
On an earnings call, DarioHealth CEO Erez Raphael told investors the fourth quarter of 2016 “seriously advanced” the company in the...
Israel-based DarioHealth, makers of a smartphone-connected glucometer, has raised $3 million as part of a definitive agreement for a total aggregate raise of $5.1 million. Crowdfunding equity platform OurCrowd Qure led the investment round. The company, which has also done business as LabStyle, said it will use the funding to expand the company’s existing markets as well as move into new...
Three months after DarioHealth launched its smartphone-connected glucometer in the US, the company reports more than 100 percent increase in growth, bringing in $669,000 in revenue in the second quarter for 2016.
The increase is understandable, considering the US is the largest market for blood glucose markets. Israel-based Dario (which has rebranded itself, after previously operating under the...
